旁观者
发表于 2025-3-23 10:28:20
,Medicines and Intellectual Property: 10 Years of the WHO Global Strategy,e to produce affordable medicines for diseases that affect the greater part of the world’s population living in developing countries. The intellectual property (IP) rights imposed by the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the trade agreements could become
浪费时间
发表于 2025-3-23 16:40:49
Book‘‘‘‘‘‘‘‘ 2022lation to drugs and vaccines — that wouldenable a response to the COVID-19 pandemic or to subsequent crises that may arise. Among the topics covered:.COVID-19 Vaccines: Between Ethics, Health and Economics.Medicines and Intellectual Property: 10 Years of the WHO Global Strategy.Re-thinking Global an
Canvas
发表于 2025-3-23 20:42:22
http://reply.papertrans.cn/99/9803/980209/980209_13.png
调味品
发表于 2025-3-24 00:47:48
2192-3698 subsequent crises that may arise. Among the topics covered:.COVID-19 Vaccines: Between Ethics, Health and Economics.Medicines and Intellectual Property: 10 Years of the WHO Global Strategy.Re-thinking Global an978-3-030-89124-4978-3-030-89125-1Series ISSN 2192-3698 Series E-ISSN 2192-3701
南极
发表于 2025-3-24 05:06:03
http://reply.papertrans.cn/99/9803/980209/980209_15.png
SNEER
发表于 2025-3-24 10:35:10
http://reply.papertrans.cn/99/9803/980209/980209_16.png
轻率的你
发表于 2025-3-24 11:35:58
Germán Velásqueznt die Marke auch vor selbst verursachten Fehlern und Angriffen von Wettbewerbern schützen kann, so unklar sind hingegen die Indikatoren für Brand Attachment und die Wirkungen des Brand Attachment. Zudem wurden meist nur psychologische Ansätze in das Marketing transferiert, statt einen systematische
gnarled
发表于 2025-3-24 17:45:59
http://reply.papertrans.cn/99/9803/980209/980209_18.png
疏忽
发表于 2025-3-24 19:10:45
Intellectual Property and Access to Medicines and Vaccines, The second part describes and defines some basic terms and concepts of this relatively new area of pharmaceutical policies which are the trade-related aspects of intellectual property rights that regulate the research, development and supply of medicines and health technologies in general.
zonules
发表于 2025-3-25 02:32:17
Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock,t there is an urgent need to re-design the global public health governance for health R&D. The adoption of a binding instrument – as allowed by Article 19 of the WHO Constitution – on this matter was proposed many years ago. This brief argues that it is time to revive and materialise this initiative.